Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07125833 · ClinicalTrials.gov registry record · NA
Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)
A NA study of Degenerative Joint Disease of Shoulder, sponsored by North Texas Medical Research Institute, P.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07125833 is a NA study of Degenerative Joint Disease of Shoulder that is actively recruiting participants, run by North Texas Medical Research Institute, P. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07125833, a NA study of Degenerative Joint Disease of Shoulder, is actively recruiting participants, sponsored by North Texas Medical Research Institute, P.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this research is to find out if a treatment called cryoneurolysis can reduce pain after reverse total shoulder replacement surgery. This treatment uses cold to temporarily block a nerve in the shoulder. The study will compare people who receive the treatment to those who do not, to see if it helps lower pain and reduce the need for opioid pain medications after a reverse total shoulder surgery (RTSA).
Conditions Studied
Interventions
- DEVICE Cryoneurolysis
- OTHER No cryoneurolysis
Study Locations (1)
Texas
- Orthopaedic Specialists of Dallas - Rockwall
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-07-30 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07125833
The ClinicalTrials.gov registry entry for NCT07125833 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Texas Medical Research Institute, P, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Degenerative Joint Disease of Shoulder appearing as the primary indexed condition, and to 2 interventions - of which Cryoneurolysis is the first listed.
NCT07125833 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07125833 about?
NCT07125833 is a clinical study titled "Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)". The main purpose of this research is to find out if a treatment called cryoneurolysis can reduce pain after reverse total shoulder replacement surgery. This treatment uses cold to temporarily block a nerve in the shoulder. The study will compare people who receive the treatment to those who do not, ...
What is the current status of trial NCT07125833?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-07-30. Estimated completion is 2026-08.
What conditions does trial NCT07125833 study?
This clinical trial studies the following conditions: Degenerative Joint Disease of Shoulder.
What interventions are being tested in trial NCT07125833?
The interventions under investigation include: Cryoneurolysis (DEVICE), No cryoneurolysis (OTHER).
Who is sponsoring clinical trial NCT07125833?
This trial is sponsored by North Texas Medical Research Institute, P, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07125833 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.